Canadian Medical Center Co.

As of June 30, 2026, Canadian Medical Center Co. carries a market capitalization of 438.90M, placing it among publicly traded companies globally. Its enterprise value stands at 417.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Canadian Medical Center Co. has 77.00M shares outstanding.

As of June 30, 2026, Canadian Medical Center Co. trades at a trailing price-to-earnings ratio of 50.12. The price-to-sales ratio is 2.70, and the price-to-book ratio stands at 4.63.

As of June 30, 2026, Canadian Medical Center Co. trades at an EV/EBITDA multiple of 16.44 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.57 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.13 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Canadian Medical Center Co. trades at an EV/FCF ratio of 50.46, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 417.80M versus a market cap of 438.90M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Canadian Medical Center Co. maintains a current ratio of 3.66, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.81, indicating elevated leverage, while an interest coverage ratio of 26.72 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Canadian Medical Center Co. posted a return on equity (ROE) of 9.09, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.05 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.14, useful for judging operating efficiency across full business cycles. Inventory turnover of 28.38 indicates how many times Canadian Medical Center Co. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Canadian Medical Center Co. recorded 2.03M in income tax expense. That works out to an effective tax rate of 18.80, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.78M, leaving 8.76M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Canadian Medical Center Co.'s stock has declined approximately 49.09% over the past 52 weeks. The 50-day moving average sits at 5.15, while the 200-day moving average is 5.63.

Over the twelve months ended June 30, 2026, Canadian Medical Center Co. generated 162.59M in revenue and converted that into 8.76M in net income, yielding earnings per share of 0.11. EBITDA reached 25.41M, while operating income came in at 18.07M.

As of June 30, 2026, Canadian Medical Center Co. holds 30.40M in cash and equivalents against 9.30M in total debt, resulting in a net debt position of -1.27M. Total book value stands at 94.78M, with working capital of 79.39M providing operational flexibility.

Canadian Medical Center Co. produced 12.08M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.57M in capital expenditures, free cash flow totaled 7.51M - equivalent to 0.10 per share.

Over the twelve months ended June 30, 2026, Canadian Medical Center Co. posted a gross margin of 27.49, reflecting its pricing power and cost economics. The operating margin of 11.11 and net profit margin of 5.39 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Canadian Medical Center Co. paid dividends of 0.05 per share. The dividend payout ratio of 43.97 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 1.71, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.20, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Canadian Medical Center Co. shareholders.

Canadian Medical Center Co.'s most recent stock split took place on June 21, 2023 with a 1:10 split ratio.

As of June 30, 2026, Canadian Medical Center Co. has an Altman Z-Score of 8.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.